190 related articles for article (PubMed ID: 19118055)
1. SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer.
Moss AC; Jacobson GM; Walker LE; Blake NW; Marshall E; Coulson JM
Clin Cancer Res; 2009 Jan; 15(1):274-83. PubMed ID: 19118055
[TBL] [Abstract][Full Text] [Related]
2. Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer.
Chen LC; Brown AB; Cheung IY; Cheung NK; Kris MG; Krug LM
Lung Cancer; 2010 Feb; 67(2):216-20. PubMed ID: 19457569
[TBL] [Abstract][Full Text] [Related]
3. Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by promoter methylation and silencing of the retinoic acid receptor-beta.
Oshita F; Sekiyama A; Suzuki R; Ikehara M; Yamada K; Saito H; Noda K; Miyagi Y
Oncol Rep; 2003; 10(1):105-8. PubMed ID: 12469153
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of the neuron restrictive silencer factor permits transcription of glycine receptor alpha1 subunit in small-cell lung cancer cells.
Gurrola-Diaz C; Lacroix J; Dihlmann S; Becker CM; von Knebel Doeberitz M
Oncogene; 2003 Aug; 22(36):5636-45. PubMed ID: 12944912
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of surfactant protein D mRNA in peripheral blood of lung cancer patients].
Qi ZL; Xiao L; Gao YT; Du JM; Jing L
Ai Zheng; 2002 Jul; 21(7):772-5. PubMed ID: 12479105
[TBL] [Abstract][Full Text] [Related]
6. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
[TBL] [Abstract][Full Text] [Related]
7. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
Bogos K; Renyi-Vamos F; Dobos J; Kenessey I; Tovari J; Timar J; Strausz J; Ostoros G; Klepetko W; Ankersmit HJ; Lang G; Hoda MA; Nierlich P; Dome B
Clin Cancer Res; 2009 Mar; 15(5):1741-6. PubMed ID: 19240177
[TBL] [Abstract][Full Text] [Related]
8. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
9. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
10. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer.
Holdenrieder S; von Pawel J; Dankelmann E; Duell T; Faderl B; Markus A; Siakavara M; Wagner H; Feldmann K; Hoffmann H; Raith H; Nagel D; Stieber P
Clin Cancer Res; 2008 Dec; 14(23):7813-21. PubMed ID: 19047109
[TBL] [Abstract][Full Text] [Related]
11. ProGRP: a new biomarker for small cell lung cancer.
Molina R; Filella X; Augé JM
Clin Biochem; 2004 Jul; 37(7):505-11. PubMed ID: 15234231
[TBL] [Abstract][Full Text] [Related]
12. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.
Ceppi P; Novello S; Cambieri A; Longo M; Monica V; Lo Iacono M; Giaj-Levra M; Saviozzi S; Volante M; Papotti M; Scagliotti G
Clin Cancer Res; 2009 Feb; 15(3):1039-45. PubMed ID: 19188177
[TBL] [Abstract][Full Text] [Related]
13. A "live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells.
Bevilacqua S; Gallo M; Franco R; Rossi A; De Luca A; Rocco G; Botti G; Gridelli C; Normanno N
Lung Cancer; 2009 Jul; 65(1):123-5. PubMed ID: 19261349
[TBL] [Abstract][Full Text] [Related]
14. Raised serum urea predicts for early death in small cell lung cancer.
Winter MC; Potter VA; Woll PJ
Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):745-50. PubMed ID: 18845424
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A, a significant prognostic factor in small cell lung cancer.
Drivsholm L; Paloheimo LI; Osterlind K
Br J Cancer; 1999 Oct; 81(4):667-71. PubMed ID: 10574253
[TBL] [Abstract][Full Text] [Related]
16. Determining the cut-off value of pro-gastrin releasing peptide (ProGRP) in lung cancer according to population characteristics.
Bubanović G; Pavićević R; Franjević A
Coll Antropol; 2008 Dec; 32(4):1155-64. PubMed ID: 19149223
[TBL] [Abstract][Full Text] [Related]
17. IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines.
Lan MS; Russell EK; Lu J; Johnson BE; Notkins AL
Cancer Res; 1993 Sep; 53(18):4169-71. PubMed ID: 8364910
[TBL] [Abstract][Full Text] [Related]
18. Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients.
Kato T; Sato N; Takano A; Miyamoto M; Nishimura H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2008 Apr; 14(8):2363-70. PubMed ID: 18413826
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.
Ma PC; Blaszkowsky L; Bharti A; Ladanyi A; Kraeft SK; Bruno A; Skarin AT; Chen LB; Salgia R
Anticancer Res; 2003; 23(1A):49-62. PubMed ID: 12683352
[TBL] [Abstract][Full Text] [Related]
20. [Chromogranin A in blood--a useful tumor marker].
Syversen U; Heide LS; Waldum HL
Tidsskr Nor Laegeforen; 1997 Oct; 117(26):3810-1. PubMed ID: 9417686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]